US OptionsDetailed Quotes

CNMD250117P110000

Watchlist

0.00
0.000.00%

15min DelayClose Jan 8 09:30 ET

0.00High0.00Low

ConMed Stock Discussion

wooper

Feb 20, 2024 06:58

excellent

Share Your Profit/Loss

Moomoo AI

Dec 18, 2023 06:02

CONMED's ROE is deemed 'sub-optimal'. The business isn't thrilling as it uses high debt to boost sub-par returns. Theoretically, greater ROE could improve through leverage, but higher debt presents greater risk.

With A 7.3% Return On Equity, Is CONMED Corporation (NYSE:CNMD) A Quality Stock?

Moomoo AI

Nov 3, 2023 09:38

CONMED's stock appears overpriced when gauged against the industry average PE ratio. Despite its positive outlook being factored into its valuation, the elevated price could present a risk to potential sellers and isn't the optimum entry point for potential investors.

Is It Time To Consider Buying CONMED Corporation (NYSE:CNMD)?

Moomoo AI

Oct 13, 2023 08:28

CONMED's move to profitability is typically seen as a good sign but investor sentiment may be changing due to recent share price drop. The company exhibits two cautionary signs for investors.

CONMED's (NYSE:CNMD) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth

Moomoo Breakfast US

Jun 1, 2022 07:21

Columns Today's pre-market stock movers: CRM, WB, LI, NIO and more

Gainers:
• $Victoria's Secret (VSCO.US)$ +10.4% (In reaction to earnings)
• $Salesforce (CRM.US)$ +9.0% (In reaction to earnings)
• $Navigator (NVGS.US)$ +4.9% (names Mads Peter Zacho as CEO)
• $Weibo (WB.US)$ +4.7% (In reaction to earnings)
• $CAE Inc (CAE.US)$ +4.7% (In reaction to earnings)
• $Laredo Petroleum (LPI.US)$ +4% (authorized $200 mln share repurchase program)
• $Axsome Therapeutics (AXSM.US)$ +3.1% (Late-Breaking Presentations of P...

No comment yet